Effects of guideline adherence in primary breast cancer-A 5-year multi-center cohort study of 3976 patients

Breast

Volumn 19, Issue 2, 2010, Pages 120-127

  Wöckel, Achim ^a   Kurzeder, Christian ^a   Geyer, Verena ^a   Novasphenny, Igor ^b   Wolters, Regine ^b   Wischnewsky, Manfred ^b   Kreienberg, Rolf ^a   Varga, Dominic ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

5 Year survival; Adherence; Breast cancer; Guideline; Therapy

Indexed keywords

GONADORELIN; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COMORBIDITY; DISEASE FREE SURVIVAL; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; OVERALL SURVIVAL; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 77951206732     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.12.006     Document Type: Article

References (21)

1. Giersiepen K., Heitmann C., Janhsen K., Lange C. Brustkrebs. Gesundheitsberichterstattung des Bundes 2005, Robert-Koch-Institut, Issue 25.
2. Statistisches Bundesamt Deutschland http://www.destatis.de/jetspeed/portal/search/results.psml.
3. Kreienberg R. Interdisziplinäre S 3-Leitlinie für die Diagnostik und therapie des Mammakarzinoms der Frau 2004, For the German cancer Society, Zuckschwerdt Verlag, Munich.
4. Lorenz W., Ollenschläger G., Geraedts M., Gerlach F., Gangjour A., Helou A., et al. Guideline developement. German J Evid Med 2001, 95:1-84.
5. Kopp I. Methodenreport zur S3-Leitlinie " Diagnostik, therapie und Nachsorge des Mammakarzinoms 2008, for the German Cancer Society, Zuckschwerdt Verlag, Munich.
6. Europarat Entwicklung einer Methodik für die Ausarbeitung von Leitlinien für optimale medizinische Praxis. Empfehlung Rec (2001) 13 des Europarates und Erläuterndes Memorandum. German Edition. Z Arztl Fortbild Qualitatssich 2002, 96:1-60.
7. Black N., Murphy M., Lamping D., McKee M., Sanderson C., Askham J., et al. Consensus development methods: a review of best practice in creating clinical guidelines. J Health Serv Res Policy 1999, 4:236-248.
8. Delbecq A.L., Van de Ven A.H., Gustafson D.H. Group techniques for program planning 1975, Scott, Foresman and Company, Glenview, IL.
9. Scottish Intercollegiate Guidelines Network A Guideline developers handbook. SIGN publication No. 50 [Accessed 1 2007]. http://www.sign.ac.uk/guidelines/fulltext/50/index.html.-
10. Brucker S.Y., Schumacher C., Sohn C., Rezai M., Bamberg M., Wallwiener D., et al. Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept. BMC Cancer 2008, 8:358-364.
11. Schmidt M., Victor A., Bratzel D., Boehm D., Cotarelo C., Lebrecht A., et al. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer-comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol 2008, 29.
12. Lee A.H., Ellis I.O. The Nottingham prognostic index for invasive carcinoma of the breast. Pathol Oncol Res. 2008, 14:113-115.
13. Schwamm L.H., Fonarow G.C., Reeves M.J., Pan W., Frankel M.R., Smith E.E., et al. Get with the guidelines-stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2008, 15.
14. Van der Wel M., Bakx C., de Grauw W., van Gerwen W., Mulder J., van Weel C. The influence of guideline revisions on the process and outcome of hypertension management in general practice: a descriptive study. Eur J Gen Pract 2008, 14:47-52.
15. Hamaker M.E., Schreurs W.H., Uppelschoten J.M., Smorenburg C.H. Breast cancer in the elderly: retrospective study on diagnosis and treatment according to national guidelines. Breast J 2009, 15:26-33.
16. Hebert-Croteau N., Brisson J., Latreille J., Rivard M., Abdelaziz N., Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clinical Oncology 2004, 22:3685-3693.
17. Dressler L.G., Berry D.A., Broadwater G., Cowan D., Cox K., Griffin S., et al. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients. J Clin Oncol 2005, 19:4287-4297.
18. Hakkennes S., Dodd K. Guideline implementation in allied health professions: a systematic review of the literature. Qual Saf Health Care 2008, 17:296-300.
19. Fernandez R.S., Davidson P., Griffiths R. Cardiac rehabilitation coordinators' perceptions of patient-related barriers to implementing cardiac evidence-based guidelines. J Cardiovasc Nurs 2008, 23:449-457.
20. Weinert C.R., Mann H.J. The science of implementation: changing the practice of critical care. Curr Opin Crit Care 2008, 14:460-465.
21. Vitry A.I., Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust 2008, 189:360-365.